Non Invasive Breath Based Acetone-meter- Easy Check
NCT01530347 · Status: TERMINATED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2018-05-15
Summary
Segment 1- this segment will include two main steps:
Step 1-Calibration: During this step we plan to collect paired measurements of capillary blood glucose using reference method and data generated by the non invasive study device. Samples will be obtained at specific time points during 4 hours: at fasting, and after consuming standard liquid meal at 60, 120, 180 and 240 minutes. At each time point capillary blood glucose will be measured using the invasive reference method. The paired reference and study device data will be analyzed using multivariate regression model to formulate a calibration algorithm model. This model will convert the acetone values measured by study device to blood glucose values.
step 2-Validation: During this segment the second step of this segment we plan to evaluate the validity and reliability of the non-invasive breath-based glucometer compared to standard invasive reference glucometer. Results will be compared using a Clark error grid.
Segment 2- During this segment we plan to collect paired measurements of capillary blood glucose beta Hydroxybutyrate using reference method and acetone values generated by the non invasive breath based study device. Samples will be obtained at specific time points during 4 hours after overnight fasting, while basal insulin will be suspended, which is accepted to produce ketosis.
Conditions
Interventions
- DEVICE
-
Easy Check
Collection of paired measurements of capillary blood glucose using reference method and data generated by the non invasive study device. Samples will be obtained at specific time points during 4 hours: at fasting, and after consuming standard liquid meal at 60, 120, 180 and 240 minutes.
Sponsors & Collaborators
-
Rabin Medical Center
lead OTHER
Principal Investigators
-
Moshe Phillip, Prof · Rabin Medical Center
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-03-31
- Primary Completion
- 2012-07-31
- Completion
- 2012-07-31
Countries
- Israel
Study Locations
More Related Trials
-
The Metabolic Effects of Acute Hyperglycemia in Patients With Type 2 Diabetes
NCT00653510 ·Status: COMPLETED ·Phase: NA
-
Compliance With American Diabetes Association Treatment Guidelines for Adult Ketoacidosis
NCT00589680 ·Status: COMPLETED
-
Beta Cell Imaging in T1D Patients With a Different Glycemic Control
NCT03785275 ·Status: TERMINATED
-
Renal Denervation in Diabetes.
NCT02081989 ·Status: WITHDRAWN ·Phase: PHASE4
-
Monitoring Glucose Levels in Patients With Myocardial Infarction
NCT03107806 ·Status: TERMINATED ·Phase: NA
-
Ketoacidosis in Individuals With Type I Diabetes Mellitus (T1DM)
NCT00970567 ·Status: COMPLETED ·Phase: NA
-
Screening Program for Type 1 Diabetes in a High-Risk Population
NCT06513247 ·Status: RECRUITING
-
The GlucoPred Investigation II
NCT02595580 ·Status: TERMINATED ·Phase: NA
-
Investigation of a Sub-Conjunctival Insert
NCT00999856 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Progression of Diabetic Retinopathy With Rapid Correction of Hyperglycemia
NCT02326259 ·Status: COMPLETED
-
Reproducibility of Glucose Fluctuations by Standardized Exercise for Patients With Type 1 Diabetes - a Method Study Based on Continuous Glucose Monitoring
NCT02942069 ·Status: COMPLETED
-
Very-Low-Density-Lipoprotein-Triglyceride(VLDL-TG) Metabolism During Acute Hyperglycemia
NCT01178957 ·Status: COMPLETED
-
Recurrent Hypoglycemia in Type 1 Diabetes (Aim 1)
NCT03410277 ·Status: COMPLETED ·Phase: NA
-
Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide
NCT03566511 ·Status: TERMINATED ·Phase: PHASE2
-
Corticosteroids and Hemoglobin A1C Levels in Diabetic Patients With COPD Exacerbation
NCT01798420 ·Status: COMPLETED
-
Electrocardiographic Modifications and Spontaneous Hypoglycemic Episodes in Type 1 Diabetes
NCT03682250 ·Status: TERMINATED
-
Repeatability of Blood Glucose Responses to Resistance Exercise in Type 1 Diabetes
NCT05168488 ·Status: COMPLETED ·Phase: NA
-
Regulation of Brain Glucose Metabolism in Type 1 Diabetes
NCT05317455 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Exercise, Glucose Kinetics, and the Incretin Effect
NCT01607931 ·Status: COMPLETED ·Phase: NA
-
Retinal Function in Relation to Transient or Chronic Challenges to Retinal Metabolism
NCT01721811 ·Status: UNKNOWN ·Phase: NA
-
Ischemic Injury and Ischemic Preconditioning in Diabetes
NCT00184821 ·Status: COMPLETED
-
Effect of Acute Hyperglycemia on Renal Tissue Oxygenation
NCT02346149 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Beta Cell Function in (Pre) Type 1 Diabetes
NCT00800085 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Cardiovascular Effects of Exercise-related Hypoglycaemia in Patients With Type 1 Diabetes (Hypo Heart Exercise)
NCT04650646 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Metformin as add-on Therapy in Non-Diabetic Heart Failure Patients
NCT05177588 ·Status: COMPLETED ·Phase: PHASE4